Postmarketing Safety Reporting-Human Drug & Biological Products Including Vaccines

Documents

Comments

Key Dates

Comment Period OpensMay 11, 2001

Comment Period ClosesMay 12, 2001

Type	Title	Posted	Comments	Status
Notice	Draft Guidance for Industry on Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines; Availability	Mar 27, 2015	22

Total Comments

SAFETY

HUMAN DRUG

VACCINES

BIOLOGICAL PRODUCT

REPORTING

POSTMARKETING

INDUSTRY

DRAFT GUIDANCE

cder